These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
175 related articles for article (PubMed ID: 32117908)
1. Prioritizing Gene Cascading Paths to Model Colorectal Cancer Through Engineered Organoids. Ping Y; Xu C; Xu L; Liao G; Zhou Y; Deng C; Lan Y; Yu F; Shi J; Wang L; Xiao Y; Li X Front Bioeng Biotechnol; 2020; 8():12. PubMed ID: 32117908 [TBL] [Abstract][Full Text] [Related]
2. CRISPR-Cas9-mediated gene knockout in intestinal tumor organoids provides functional validation for colorectal cancer driver genes. Takeda H; Kataoka S; Nakayama M; Ali MAE; Oshima H; Yamamoto D; Park JW; Takegami Y; An T; Jenkins NA; Copeland NG; Oshima M Proc Natl Acad Sci U S A; 2019 Jul; 116(31):15635-15644. PubMed ID: 31300537 [TBL] [Abstract][Full Text] [Related]
3. Modeling colorectal cancer using CRISPR-Cas9-mediated engineering of human intestinal organoids. Matano M; Date S; Shimokawa M; Takano A; Fujii M; Ohta Y; Watanabe T; Kanai T; Sato T Nat Med; 2015 Mar; 21(3):256-62. PubMed ID: 25706875 [TBL] [Abstract][Full Text] [Related]
4. Mutations of key driver genes in colorectal cancer progression and metastasis. Huang D; Sun W; Zhou Y; Li P; Chen F; Chen H; Xia D; Xu E; Lai M; Wu Y; Zhang H Cancer Metastasis Rev; 2018 Mar; 37(1):173-187. PubMed ID: 29322354 [TBL] [Abstract][Full Text] [Related]
5. Organoids Are Limited in Modeling the Colon Adenoma-Carcinoma Sequence. Tokumaru Y; Oshi M; Patel A; Tian W; Yan L; Matsuhashi N; Futamura M; Yoshida K; Takabe K Cells; 2021 Feb; 10(3):. PubMed ID: 33668713 [TBL] [Abstract][Full Text] [Related]
6. Organoid Culture of Isolated Cells from Patient-derived Tissues with Colorectal Cancer. Xie BY; Wu AW Chin Med J (Engl); 2016 Oct; 129(20):2469-2475. PubMed ID: 27748340 [TBL] [Abstract][Full Text] [Related]
7. Acquired somatic Chang PY; Chen JS; Chang SC; Wang MC; Chang NC; Wen YH; Tsai WS; Liu WH; Liu HL; Lu JJ Oncotarget; 2017 Sep; 8(42):72352-72362. PubMed ID: 29069792 [TBL] [Abstract][Full Text] [Related]
8. Genetic Alterations and Microenvironment that Drive Malignant Progression of Colorectal Cancer: Lessons from Mouse and Organoid Models. Nakayama M; Wang D; Kok SY; Oshima H; Oshima M J Cancer Prev; 2022 Mar; 27(1):1-6. PubMed ID: 35419304 [TBL] [Abstract][Full Text] [Related]
9. Combined Mutation of Sakai E; Nakayama M; Oshima H; Kouyama Y; Niida A; Fujii S; Ochiai A; Nakayama KI; Mimori K; Suzuki Y; Hong CP; Ock CY; Kim SJ; Oshima M Cancer Res; 2018 Mar; 78(5):1334-1346. PubMed ID: 29282223 [TBL] [Abstract][Full Text] [Related]
10. Gene promoter and exon DNA methylation changes in colon cancer development - mRNA expression and tumor mutation alterations. Molnár B; Galamb O; Péterfia B; Wichmann B; Csabai I; Bodor A; Kalmár A; Szigeti KA; Barták BK; Nagy ZB; Valcz G; Patai ÁV; Igaz P; Tulassay Z BMC Cancer; 2018 Jun; 18(1):695. PubMed ID: 29945573 [TBL] [Abstract][Full Text] [Related]
11. Driver mutations of the adenoma-carcinoma sequence govern the intestinal epithelial global translational capacity. Smit WL; Spaan CN; Johannes de Boer R; Ramesh P; Martins Garcia T; Meijer BJ; Vermeulen JLM; Lezzerini M; MacInnes AW; Koster J; Medema JP; van den Brink GR; Muncan V; Heijmans J Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25560-25570. PubMed ID: 32989144 [TBL] [Abstract][Full Text] [Related]
12. A pair of primary colorectal cancer-derived and corresponding synchronous liver metastasis-derived organoid cell lines. Cheng F; Li P; Xu S; Zhang C; Liang H; Ding Z Aging (Albany NY); 2024 Feb; 16(5):4396-4422. PubMed ID: 38407980 [TBL] [Abstract][Full Text] [Related]
14. Mutation analysis of 13 driver genes of colorectal cancer-related pathways in Taiwanese patients. Chang YC; Chang JG; Liu TC; Lin CY; Yang SF; Ho CM; Chen WT; Chang YS World J Gastroenterol; 2016 Feb; 22(7):2314-25. PubMed ID: 26900293 [TBL] [Abstract][Full Text] [Related]
15. Genomic alterations in signet ring and mucinous patterned colorectal carcinoma. Kim H; Kim BH; Lee D; Shin E Pathol Res Pract; 2019 Oct; 215(10):152566. PubMed ID: 31400926 [TBL] [Abstract][Full Text] [Related]
16. Targeting mutant RAS in patient-derived colorectal cancer organoids by combinatorial drug screening. Verissimo CS; Overmeer RM; Ponsioen B; Drost J; Mertens S; Verlaan-Klink I; Gerwen BV; van der Ven M; Wetering MV; Egan DA; Bernards R; Clevers H; Bos JL; Snippert HJ Elife; 2016 Nov; 5():. PubMed ID: 27845624 [TBL] [Abstract][Full Text] [Related]
17. A Bioinformatic Profile of Gene Expression of Colorectal Carcinoma Derived Organoids. A P; Xu X; Wang C; Ye L; Yang J Biomed Res Int; 2018; 2018():2594076. PubMed ID: 30363662 [TBL] [Abstract][Full Text] [Related]
18. Systematic evaluation of colorectal cancer organoid system by single-cell RNA-Seq analysis. Wang R; Mao Y; Wang W; Zhou X; Wang W; Gao S; Li J; Wen L; Fu W; Tang F Genome Biol; 2022 Apr; 23(1):106. PubMed ID: 35484598 [TBL] [Abstract][Full Text] [Related]
19. Intestinal multicellular organoids to study colorectal cancer. Idris M; Alves MM; Hofstra RMW; Mahe MM; Melotte V Biochim Biophys Acta Rev Cancer; 2021 Dec; 1876(2):188586. PubMed ID: 34216725 [TBL] [Abstract][Full Text] [Related]
20. Circulating Tumor DNA Is Capable of Monitoring the Therapeutic Response and Resistance in Advanced Colorectal Cancer Patients Undergoing Combined Target and Chemotherapy. Cao H; Liu X; Chen Y; Yang P; Huang T; Song L; Xu R Front Oncol; 2020; 10():466. PubMed ID: 32318348 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]